Renal Cancer
Impact of a kidney-adjusted ERASĀ® protocol on postoperative outcomes in patients undergoing partial nephrectomy.
October 29, 2024
T1a renal cancer cryoablation - first experiences in Poland.
October 28, 2024
Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learning.
October 28, 2024
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.
October 25, 2024
Beyond Index Conditions: Applying a Multimorbidity Approach to Renal Cancer Nursing.
October 25, 2024
Resveratrol enhances sensitivity of renal cell carcinoma to tivozanib: An in-vitro study.
October 24, 2024
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors.
October 23, 2024
Prognosis and progression of phagocytic regulatory factor-related gene combinations in clear cell renal cell carcinoma (ccRCC).
October 22, 2024
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.
October 21, 2024
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration.
October 21, 2024
Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study.
October 18, 2024
Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings.
October 17, 2024